Trial Profile
An open-label, single-center, randomized-sequence, three-treatment/period crossover study to evaluate the effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Eluxadoline (Primary) ; Probenecid
- Indications Irritable bowel syndrome
- Focus Pharmacokinetics
- 25 Nov 2015 New trial record